These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9234267)

  • 21. Visualization of prostate cancer with 11C-choline positron emission tomography.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    Eur Urol; 2002 Jul; 42(1):18-23. PubMed ID: 12121724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
    Picchio M; Landoni C; Messa C; Gianolli L; Matarrese M; De Cobelli F; Maschio AD; Fazio F
    AJR Am J Roentgenol; 2002 Aug; 179(2):482-4. PubMed ID: 12130458
    [No Abstract]   [Full Text] [Related]  

  • 24. Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine.
    Hwang DR; Mathias CJ; Welch MJ; McGuire AH; Kadmon D
    Int J Rad Appl Instrum B; 1990; 17(6):525-32. PubMed ID: 2254090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
    Tabrizipour AI; Dunne M
    Clin Nucl Med; 2015 May; 40(5):e285-6. PubMed ID: 25608148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT superscan in prostate cancer.
    Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
    Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
    Rose DM; Delbeke D; Beauchamp RD; Chapman WC; Sandler MP; Sharp KW; Richards WO; Wright JK; Frexes ME; Pinson CW; Leach SD
    Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron tomographic assessment of androgen receptors in prostatic carcinoma.
    Dehdashti F; Picus J; Michalski JM; Dence CS; Siegel BA; Katzenellenbogen JA; Welch MJ
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):344-50. PubMed ID: 15726353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
    Garcia JR; Moreno C; Valls E; Cozar P; Bassa P; Soler M; Alvarez-Moro FJ; Moragas M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):155-61. PubMed ID: 25443648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
    Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
    J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
    [No Abstract]   [Full Text] [Related]  

  • 34. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
    Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
    J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic performance of
    Kitajima K; Fukushima K; Yamamoto S; Kato T; Odawara S; Takaki H; Fujiwara M; Yamakado K; Nakanishi Y; Kanematsu A; Nojima M; Hirota S
    Nagoya J Med Sci; 2017 Aug; 79(3):387-399. PubMed ID: 28878443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses?
    Rasmussen I; Sörensen J; Långström B; Haglund U
    Scand J Surg; 2004; 93(3):191-7. PubMed ID: 15544073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.
    Hofer C; Laubenbacher C; Block T; Breul J; Hartung R; Schwaiger M
    Eur Urol; 1999; 36(1):31-5. PubMed ID: 10364652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
    Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
    Clin Nucl Med; 2015 May; 40(5):e265-70. PubMed ID: 25783519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer.
    Sung J; Espiritu JI; Segall GM; Terris MK
    BJU Int; 2003 Jul; 92(1):24-7. PubMed ID: 12823377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.